Ping An Healthcare and Technology Company Limited (1833.HK) Bundle
Born in 2014 as a subsidiary of Ping An Insurance and listed on the Hong Kong Stock Exchange under 1833.HK, Ping An Healthcare and Technology (Ping An Good Doctor) has evolved from its 2015 platform launch into one of China's leading digital-health ecosystems-boasting over 300 million registered users (with more than 50 million monthly active users in 2020) and a market capitalization of about HKD 31.54 billion as of December 16, 2025; the company combines online consultations, hospital referrals, subscription health management, AI-driven diagnostic tools introduced in 2021, insurance agency services and value-added offerings, leverages a broad provider network and integration with Ping An's financial services, and is rapidly expanding corporate health management-serving over 87,000 corporate clients as of September 30, 2025-while rolling out senior-care services across 64 cities and continuing to monetize through consultations, subscriptions, corporate contracts, insurance sales and platform advertising.
Ping An Healthcare and Technology Company Limited (1833.HK): Intro
Founded as a digital-health arm of Ping An Insurance (Group) Company of China, Ltd., Ping An Healthcare and Technology Company Limited (1833.HK) has developed Ping An Good Doctor into one of China's largest online healthcare platforms.- Incorporated: 2014 as a Ping An subsidiary focused on online healthcare and wellness services.
- Flagship launch: 2015 - Ping An Good Doctor (online consultations, hospital referrals, health management).
- Service expansion: 2018 - added health check-ups and beauty care services to broaden offerings.
- User scale (2020): >300 million registered users; >50 million monthly active users.
- Technology integration: 2021 - introduced AI-powered health management tools for triage, decision support and personalized care pathways.
- Strategy through late 2025: continuing innovation in insurance-healthcare integration and expanding corporate health management business.
| Year | Milestone | Key Metrics / Notes |
|---|---|---|
| 2014 | Incorporation | Established as Ping An's digital-health subsidiary |
| 2015 | Ping An Good Doctor launched | Online consultations, referrals, initial health management features |
| 2018 | Service diversification | Added health check-ups, beauty care services |
| 2020 | Scale expansion | >300M registered users; >50M MAU (monthly active users) |
| 2021 | AI rollout | AI-powered health management and diagnostic-support tools deployed |
| Late 2025 | Insurance + Corporate focus | Deeper integration with Ping An insurance products; corporate health management expansion |
- Parent: Ping An Insurance (Group) Company of China, Ltd.; PAHT operates as the group's healthcare & technology vehicle.
- Listed entity: Hong Kong Stock Exchange, ticker 1833.HK, positioning it as a public-facing arm of Ping An's digital-health strategy.
- Mission: digitize, scale and integrate healthcare services to improve access, efficiency and outcomes while linking health services to insurance and financial products.
- Strategic pillars: platform scale (consumers), technology (AI & data), integrated care (ecosystem of services), and enterprise solutions (corporate health and insurer linkages).
- Consumer-facing app (Ping An Good Doctor): symptom checkers, real-time online consultations with licensed physicians, prescription/e-pharmacy fulfillment, appointment booking and hospital referrals.
- AI & triage: AI-driven symptom assessment, decision support for clinicians, personalized care plans and automated health reminders.
- Value chain integration: on-platform pharmacies, offline clinic and hospital partnerships, health-check and beauty-service fulfillment networks.
- Enterprise offerings: corporate health management, employee wellness programs, and data-driven occupational health services targeted at employers and insurers.
- Consultation fees: paid online consultations and premium physician access.
- Subscription and membership products: recurring health-service packages and value-added memberships.
- Pharmacy and product sales: medicines, supplements and health products fulfilled via platform partners or in-house channels.
- Health check-ups & services: revenues from facilitation and referrals for offline check-ups, beauty and wellness services.
- Corporate contracts: fees for corporate health management, employee plans and occupational medicine solutions.
- Insurance integration and cross-sales: referrals into Ping An insurance products and joint-service bundles driving commission and embedded sales.
- Advertising & partnerships: healthcare advertising, co-marketing and technology/licensing arrangements with hospitals and providers.
| Metric | Reported / Focus |
|---|---|
| Registered users | >300 million (2020 milestone) |
| Monthly active users (MAU) | >50 million (2020 milestone) |
| Service breadth | Online consultations, pharmacy, health check-ups, beauty care, corporate health |
| Technology | AI-driven triage, clinical decision support, personalized health management (rolled out 2021) |
| Strategic priority (late 2025) | Insurance integration, scaling corporate health management, continued AI/tech investment |
- As a public company listed in Hong Kong (1833.HK), PAHT's financials reflect a mix of platform monetization and strategic reinvestment into tech and user acquisition; the company emphasizes user metrics and enterprise growth as drivers of long-term monetization.
- Revenue mix has historically reflected a blend of consumer transaction fees, product sales (pharmacy), and growing enterprise/contracts revenue as corporate healthcare services scale.
Ping An Healthcare and Technology Company Limited (1833.HK): History
Ping An Healthcare and Technology Company Limited (1833.HK) was spun out of Ping An's broader healthcare ambitions to build an integrated digital-health ecosystem combining insurance, fintech and medical services. Since its 2018 listing in Hong Kong, the company has expanded from online health consultation and digital medical records into hospital partnerships, drug retail, AI diagnostics and chronic disease management platforms.- Listed: Hong Kong Stock Exchange (1833.HK)
- Parent: Ping An Insurance (Group) Company of China, Ltd. - strategic controlling shareholder
- Primary businesses: online healthcare services, medical AI, hospital SaaS, pharmacy retail and health management
- Key growth drivers: user base expansion, platform monetization, partnerships with hospitals and insurers
- Subsidiary relationship: Ping An Healthcare and Technology is a strategic subsidiary of Ping An Insurance, enabling cross-selling to Ping An's insurance and financial customers.
- Shareholder mix: institutional investors, retail investors and Ping An Insurance (significant strategic stake)
- Synergies: integration with Ping An's insurance products, customer data and capital support to scale health services.
| Attribute | Detail |
|---|---|
| Stock code | 1833.HK |
| Listing venue | Hong Kong Stock Exchange |
| Parent company | Ping An Insurance (Group) Company of China, Ltd. |
| Market capitalization (as of 16 Dec 2025) | HKD 31.54 billion |
| Major shareholder type | Ping An Insurance (strategic), institutional investors, retail investors |
- Revenue streams:
- Fee income from online consultations and telemedicine
- Platform services and SaaS contracts with hospitals and clinics
- Retail pharmacy sales and distribution
- Data and AI-enabled services for diagnostics and disease management
- Cross-selling insurance and health-management products in partnership with Ping An Insurance
- Monetization levers: increasing paid user conversion, expanding B2B SaaS penetration, margin expansion in pharmacy retail, and higher-value partnerships with insurers and hospitals.
- Capital & strategic support: Listed status (1833.HK) provides access to international capital markets; Ping An's ownership provides distribution, customer acquisition and financing synergies.
Ping An Healthcare and Technology Company Limited (1833.HK): Ownership Structure
Ping An Healthcare and Technology Company Limited (1833.HK) (formerly Ping An Good Doctor) is a healthcare technology and online medical services platform built to integrate digital healthcare, insurance linkage, and health management for China's population. Mission and Values- Provide accessible, efficient, and comprehensive healthcare services to the Chinese population.
- Value innovation by leveraging advanced technologies, including AI, big data, and telemedicine, to enhance care delivery and user experience.
- Integrate insurance with healthcare services to offer a seamless experience for users seeking health management and post-care follow-up.
- Customer-centric focus on personalized services-symptom checkers, online consultations, chronic disease management, and tailored care plans.
- Uphold integrity and transparency to build trust and reliability in clinical, pharmaceutical, and advisory offerings.
- Commit to social responsibility through public-health initiatives, community outreach, and health literacy promotion across China.
- Core platforms: online consultation, AI-assisted diagnostic tools, pharmacy e-commerce, and health management services integrated with insurer partners.
- User acquisition through mobile app, partnerships with Ping An Group entities (insurance, banking), and enterprise/telco collaborations.
- Revenue streams: paid consultations, subscription/membership services, online pharmacy sales, value-added enterprise services, and partnerships with insurers/hospitals.
| Metric | Figure (latest reported) |
|---|---|
| Annual revenue | RMB 11.3 billion (FY 2021) |
| Net profit / (loss) | RMB (2.2) billion (FY 2021) |
| Registered users | ≈346 million (cumulative users, 2021) |
| Monthly active users (MAU) | ≈84 million (average, 2021) |
| Market listing | HKEX: 1833.HK (IPO 2018) |
- Major shareholder: Ping An Insurance (Group) Company of China (via holding vehicles)-controlling stake that provides strategic integration with Ping An's financial and insurance ecosystem.
- Public float: Listed on the Hong Kong Stock Exchange with institutional and retail investors holding the balance of shares.
- Governance: Board and management combine healthcare-tech executives and representatives linked to Ping An Group to align platform strategy with insurance and fintech services.
- Online medical consultations and value-added services (subscription/membership fees and pay-per-consult).
- Pharmacy e-commerce-direct sale of prescription and OTC drugs, logistics and fulfillment margins.
- Enterprise solutions-health-management packages sold to employers, insurers, and partners; data and analytics services.
- Insurance-linked services-cooperative programs with Ping An insurance entities that route customers into health-insurance and case-management workflows.
Ping An Healthcare and Technology Company Limited (1833.HK): Mission and Values
Ping An Healthcare and Technology Company Limited (1833.HK) (operating Ping An Good Doctor) is built around a mission to make high-quality healthcare accessible, affordable and tech-enabled for all users across China. Its core values emphasize patient-centricity, data security, technological innovation and integration with financial and insurance services to deliver preventive, diagnostic and treatment support at scale. How it works- Platform model: Operates an integrated online healthcare platform offering services including online consultations (text, voice, video), hospital referrals, appointment booking, prescription fulfillment, chronic-disease management and health content.
- Access channels: Available via mobile apps and web interfaces to ensure broad accessibility across urban and rural users in China.
- Provider network: Collaborates with an extensive network of healthcare providers - hospitals, specialist clinics, licensed physicians, pharmacies and diagnostic partners - to deliver on-demand and referral services.
- Subscription and pay-per-service: Combines a subscription-based premium service (membership tiers for faster access, specialist consultations, family/child coverage and wellness plans) with pay-per-consultation and pharmacy sales.
- Insurance integration: Deeply integrated with Ping An Insurance group products to bundle medical services with insurance coverage, claims handling and insurer-led care pathways.
- AI and data-driven care: Uses AI-driven triage, natural language processing, symptom checkers and predictive analytics to improve diagnostic accuracy, personalize care plans and streamline operations (routing to human doctors when needed).
- User journey: User signs up → completes health profile → uses AI triage/symptom checker → consults with online physician or is referred to offline care → prescription/medicine fulfilment or insurance claim initiation.
- Revenue streams: subscription fees, consultation fees (platform takes a commission), online pharmacy sales, value-added services (health management, chronic disease programs), B2B contracts with employers and hospitals, and cross-selling insurance or financial-health bundles.
- Technology stack: Combines machine learning models for symptom assessment, decision support engines, telemedicine video infrastructure, electronic medical records integration, and APIs for partner link-ups (hospitals, pharmacies, insurers).
- Quality and compliance: Clinical governance with licensed doctors, standardized clinical pathways, data privacy safeguards, and regulatory compliance for telemedicine and online pharmaceuticals in China.
| Metric | Representative figure (latest reported / approximate) | Notes |
|---|---|---|
| Founded / IPO | Founded 2014; Listed on HKEX (1833.HK) in 2018 | Spin-off of Ping An Group's digital health initiatives |
| Registered users (approx.) | ~360-420 million | Accumulated registered users on platform (consumer reach across services) |
| Annual active users (approx.) | ~90-110 million | Users with activity within 12 months (consults, purchases, subscriptions) |
| Paid/subscription members | ~8-12 million | Premium memberships and family plans generating recurring revenue |
| Annual consultations (doctor-patient interactions) | >100 million | Includes AI-assisted triage + physician consultations |
| Annual revenue (approx.) | RMB 5-8 billion | Combination of subscription, consultation fees, pharmacy and B2B |
| Integration with Ping An Group | Majority strategic partner / anchor shareholder | Enables bundling with insurance, claims automation and cross-selling |
- Subscription revenue: Recurring monthly/annual fees for premium access, family plans, and prioritized services - stabilizes cash flow and increases lifetime value per user.
- Transaction revenue: Commission and fees from single consultations, specialist referrals and pharmacy orders processed through the platform.
- Pharmacy and supply chain: Margin on medicines and health products sold via platform pharmacies and partner networks.
- B2B contracts: Corporate health packages, employee wellness programs and hospital integration services (software-as-a-service and operational partnerships).
- Insurance-linked revenue: Co-developed insurance products, streamlined claims, and risk management services sold within Ping An Group ecosystems.
- AI efficiency gains: Automation reduces physician load, shortens response times, and improves conversion of free users to paid services by personalizing offerings and follow-up.
- AI triage: Front-line symptom assessment that classifies urgency and routes users to self-care guidance, pharmacist support, online physicians or offline referrals.
- Decision support: Clinical decision support systems help physicians with differential diagnosis, guideline prompts, and prescription safety checks.
- Personalization: Machine learning models tailor health management plans (chronic disease monitoring, medication reminders, prevention nudges) based on user data and medical history.
- Operational automation: Chatbots and automated follow-ups increase throughput; analytics identify high-value cohorts for targeted subscription upgrades.
- Hospital and clinic affiliations: On-platform referrals feed tertiary and specialist hospitals; hospitals gain appointment throughput and patient retention.
- Pharmacy network: Alliances with licensed pharmacies support online prescriptions, last-mile delivery and offline pickup options.
- Corporate and insurer partners: Employers and insurers integrate Ping An Healthcare's tools for employee health management, cost containment and claim handling.
- Research and data partnerships: Aggregated, de-identified health data supports epidemiology, AI model training and preventive-care product development.
- Strategic shareholder: Ping An Insurance Group is the principal strategic backer, enabling deep integration of insurance and financial-health products.
- Governance focus: Clinical quality, data protection, regulatory compliance with China's telemedicine and pharmaceutical rules are central to sustainable growth.
- Competitive moat: Large user base, integrated insurer ecosystem, proprietary AI models and an extensive offline provider network strengthen defensibility.
Ping An Healthcare and Technology Company Limited (1833.HK): How It Works
Ping An Healthcare and Technology Company Limited (1833.HK) operates an integrated digital healthcare ecosystem combining primary-care telemedicine, specialist consultations, chronic disease management, health management services, insurance distribution and value‑added services. The business model monetizes a large user base across consumer, corporate and insurance channels through transaction fees, subscriptions, service contracts and cross‑selling.- Platform scale (indicative): hundreds of millions of registered users and tens of millions of monthly active users, providing the reach that underpins advertising, partner sales and conversion to paid services.
- Technology stack: AI triage, symptom checkers, medical knowledge graphs, remote diagnostics tools and telemedicine video/audio consultations that route users to in‑house or partner clinicians.
- Distribution: mobile app, web portals, API integrations for insurers, hospitals and corporate HR systems.
- Online consultations - fee‑per‑session and subscriptions: Users pay per consultation (fixed or tiered prices) or subscribe to membership plans for unlimited or bundled access. This is a primary transactional revenue source, especially for first‑contact care and specialist follow‑ups.
- Health management services: Recurring revenue from personalized care plans, chronic disease management programs, remote monitoring and follow‑up services, often sold as multi‑month packages or employer contracts.
- Corporate partnerships: Contracts with enterprises to provide employee health platforms, occupational health services and aggregated analytics - typically invoiced on a per‑employee or per‑contract basis.
- Insurance agency services: Commission income and referral fees by facilitating sale and servicing of health insurance products on the platform and via embedded insurance offerings.
- Advertising and promotional activities: Display ads, sponsored placement, paid health content and co‑marketing with healthcare service providers and product brands leveraging the platform's user engagement.
- Value‑added offline/auxiliary services: Revenue from ancillary services like health check‑ups, diagnostic testing, pharmacy and beauty/wellness services arranged or promoted through the platform, with either commission or margin models.
| Revenue Stream | Monetization Mechanism | Typical Pricing/Model |
|---|---|---|
| Online Consultations | Per‑session fees, expert/GP tiers, subscription bundles | One‑off fees (e.g., RMB ¥xx-¥xxx per consult) or monthly/annual memberships |
| Health Management | Subscription plans, program fees, device & remote monitoring charges | Multi‑month program fees (RMB hundreds-thousands per patient per year) |
| Corporate Solutions | Enterprise contracts, per‑employee pricing, platform licensing | Per‑employee per‑month (PEPM) or fixed annual contracts |
| Insurance Agency | Commissions, referral income, embedded insurance sales | Percentage commissions on premiums; fixed referral fees |
| Advertising & Promotions | Display ads, sponsored content, partner campaigns | CPM/CPC or fixed campaign fees tied to reach/engagement |
| Value‑Added Services | Commissions, service margins (checkups, pharmacies, beauty) | Per‑service commissions or markup on service fees |
- Conversion: Free users → paid consultations/subscriptions drives direct revenue growth; improving conversion rates increases ARPU (average revenue per user).
- Retention & LTV: Chronic‑disease programs and subscription products extend customer lifetime value via recurring revenue.
- Cross‑sell: Embedding insurance and offline services increases take‑rate per user.
- Cost control: Optimizing clinician supply (in‑house vs. third‑party), AI‑driven triage and telehealth throughput improves margin on consultations.
| Metric | Why it matters |
|---|---|
| Monthly Active Users (MAU) | Scale for advertising, conversion to paid services and partner monetization |
| Paid User Count / ARPU | Directly drives subscription and transaction revenue |
| Gross Margin on Services | Reflects efficiency of clinician supply, third‑party costs and pricing |
| Annual Recurring Revenue (ARR) from corporate contracts | Predictability and visibility into future cash flows |
| Insurance Commissions & Take‑rate | Contribution from embedded finance and cross‑sell capabilities |
- Integration with Ping An Group's insurance, banking and technology ecosystems enables bundled offerings (e.g., health + insurance) and cross‑referrals, increasing customer acquisition efficiency.
- Focus on preventive care, chronic disease management and AI‑enabled triage aims to shift revenue mix toward higher‑margin recurring services over time.
- International and domestic partnerships extend reach into hospitals, diagnostic chains and pharmaceutical channels for service and product monetization.
Ping An Healthcare and Technology Company Limited (1833.HK): How It Makes Money
Ping An Healthcare and Technology Company Limited (1833.HK) monetizes a broad ecosystem that combines digital healthcare services, insurance integration, corporate solutions and senior-care offerings. As of late 2025 the company has a registered user base exceeding 300 million and is expanding services and technology investments to drive higher monetization per user.- Core revenue streams: paid online medical consultations, telemedicine subscriptions, pharmacy and medical-product sales, and diagnostic services.
- Insurance-linked revenue: referral and platform fees from integrated insurance products and value-added insurance services tied to healthcare usage.
- Corporate & B2B: corporate health-management contracts, occupational health services, and SaaS/AI solutions for hospitals and insurers.
- Senior care & value-added services: home-based senior care fees, chronic disease management programs, and care coordination.
- Advertising & data services: targeted health advertising, analytics and API/licensing for partners.
| KPI | Value (late 2025) |
|---|---|
| Registered users | >300,000,000 |
| Corporate clients (health management) | 87,000+ |
| Home-based senior care coverage | 64 cities |
| Stock ticker | 1833.HK |
| Strategic focus | AI, tech integration, insurance-health convergence |
- Dominant platform presence in China's online healthcare market supported by scale and cross-selling into Ping An's insurance and financial ecosystem.
- Heavy investment in AI to improve diagnostic accuracy, triage efficiency and personalization-expected to increase revenue per consultation and reduce cost-to-serve.
- Corporate health expansion (87,000+ clients) provides recurring revenue and upsell pathways into chronic care and employee wellness programs.
- Senior care footprint in 64 cities opens new recurring-service and home-care monetization channels as China ages.
- Strategic partnerships and tech licensing aim to diversify income beyond direct-to-consumer services and strengthen long-term margins.
Ping An Healthcare and Technology Company Limited (1833.HK) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.